Project Grant 2442112
Award Date
7/1/25
Completion Date
6/30/30
Dollars Obligated
$600K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Binghamton, NY 13902, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) grant award of $275,000 to Envision Health Technologies Inc. aims to develop a novel adaptive perimetry software tool for earlier detection of vision loss due to glaucoma. The project objectives include mathematical modeling of glaucoma retinal pathophysiology, real-time spatial analysis for test location determination, active eye-tracking correction, and optimized suprathreshold contrast determination....
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop an accurate, safe, and wearable intraocular pressure (IOP) monitoring device for the clinical management of glaucoma. The key goals are to: 1) Develop a prototype contact lens-based IOP sensor using atomic force microscopy; 2) Establish an empirical model relating indentation measurements to IOP; and 3) Assess the impact of sensor indentation on the human...
This $976,308 National Science Foundation project grant funds the University of Miami to develop a novel fundus multiwavelength imaging device for simultaneous multiwavelength imaging of the retinal nerve fiber layer. The goal is to design, construct, and validate a non-contact optical method that can sensitively detect early glaucoma damage through in vivo measurement of retinal spectral reflectance changes. Specifically, the University of Miami will design and construct a new fundus imaging...
This $715,098 federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to enhance glaucoma risk prediction through advanced genomics and machine learning approaches. The key products and services to be delivered include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging natural language processing techniques to extract refined glaucoma phenotypes from electronic health record data across over 1 million...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...
This Project Grant award of $390,000 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to assess the biomechanical and hydrodynamic effects of different drugs and treatments on modulating outflow facility in the eye. The goals are to improve understanding of intraocular pressure regulation mechanisms and dynamic outflow resistance, which could lead to new diagnostic and therapeutic biomarkers for glaucoma. Key activities include: Measuring...
This National Eye Institute (NEI) Vision Research (CFDA 93.867) Project Grant award of $387,428 supports research to investigate fundamental mechanisms driving optic nerve sensitivity to elevated intraocular pressure (IOP) in glaucoma. The 5-year project, led by the Research Foundation for the State University of New York (Upstate Medical Center), aims to determine how transient biomechanical strains on optic nerve head astrocytes may predispose them to glaucomatous dysfunction. The research...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $409,375 to The Johns Hopkins University to conduct research on the biomechanics of the human optic nerve head for glaucoma biomarkers. The 5-year project, starting on July 1, 2024 and ending on June 30, 2029, aims to: Image the eyes of patients with primary open-angle glaucoma using optical coherence tomography to measure optic nerve head deformation in response to changes...
Aisight Health Inc. received a $479,580 Project Grant award from the National Institutes of Health's National Eye Institute to develop artificial intelligence tools to identify rapid glaucoma progression. The goal is to use machine learning models trained on over a decade of optical coherence tomography images, visual field tests, and clinical records for more than 9,000 glaucoma patients to more accurately and quickly determine which patients are likely to experience rapid vision loss from...
This federal Project Grant award of $679,159 from the National Eye Institute (NEI), under the NIH Vision Research program (CFDA 93.867), supports research to investigate the combined effects of aging and elevated intraocular pressure on the development of glaucoma and the retinal ganglion cell (RGC) transcriptome. The research aims to identify age- and glaucoma-specific transcriptomic changes, and determine how these changes are altered by in vivo transient epigenetic reprogramming using...